Synergistic Role of Curcumin With Current Therapeutics in Colorectal Cancer: Minireview

REFERENCES

• Jemal , A , Siegel , R , Ward , E , Hao , Y Xu , J . 2008 . Cancer statistics, 2008 . CA Cancer J Clin , 58 : 71 – 96 .
   PubMed Web of Science ®Google Scholar
• Andre , T , Boni , C , Mounedji-Boudiaf , L , Navarro , M Tabernero , J . 2004 . Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer . N Engl J Med , 350 : 2343 – 2351 .
   PubMed Web of Science ®Google Scholar
• Neugut , A I , Lautenbach , E , Abi-Rached , B and Forde , K A . 1996 . Incidence of adenomas after curative resection for colorectal cancer . Am J Gastroenterol , 91 : 2096 – 2098 .
   PubMed Web of Science ®Google Scholar
• O'dwyer , S T , Renehan , A G , Zwahlen , M and Egger , M . 2006 . Risk of second primary colorectal cancer with particular reference to age at diagnosis . Colorectal Dis , 9 : 814
   Google Scholar
• Shitoh , K , Konishi , F , Miyakura , Y , Togashi , K Okamolo , T . 2002 . Microsatellite instability as a marker in predicting metachronous multiple colorectal carcinomas after surgery: a cohort-like study . Dis Colon Rectum , 45 : 329 – 333 .
   PubMed Web of Science ®Google Scholar
• Hurwitz , H , Fehrenbacher , L , Novotny , W , Cartwright , T Hainsworth , J . 2004 . Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer . N Engl J Med , 350 : 2335 – 2342 .
   PubMed Web of Science ®Google Scholar
• Srinivasan , K R . 1953 . A chromatographic study of the curcuminoids in Curcuma longa, L . J Pharm Pharmacol , 5 : 448 – 457 .
   PubMed Web of Science ®Google Scholar
• Kiuchi , F , Goto , Y , Sugimoto , N , Akao , N Kondo , K . 1993 . Nematocidal activity of turmeric: synergistic action of curcuminoids . Chem Pharm Bull (Tokyo) , 41 : 1640 – 1643 .
   PubMed Web of Science ®Google Scholar
• Hanif , R , Qiao , L , Shiff , S J and Rigas , B . 1997 . Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway . J Lab Clin Med , 130 : 576 – 584 .
   PubMed Web of Science ®Google Scholar
• Chauhan , D P . 2002 . Chemotherapeutic potential of curcumin for colorectal cancer . Curr Pharm Des , 8 : 1695 – 1706 .
   PubMed Web of Science ®Google Scholar
• Huang , M T , Wang , Z Y , Georgiadis , C A , Laskin , J D and Conney , A H . 1992 . Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene . Carcinogenesis , 13 : 2183 – 2186 .
   PubMed Web of Science ®Google Scholar
• Rao , C V , Simi , B and Reddy , B S . 1993 . Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon . Carcinogenesis , 14 : 2219 – 2225 .
   PubMed Web of Science ®Google Scholar
• Rao , C V , Rivenson , Simi , B and Reddy , B S . 1995 . Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound . Cancer Res , 55 : 259 – 266 .
   PubMed Web of Science ®Google Scholar
• Huang , M T , Wang , Z Y , Georgiadis , C A , Laskin , J D and Conney , A H . 1992 . Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene . Carcinogenesis , 13 : 2183 – 2186 .
   PubMed Web of Science ®Google Scholar
• Huang , M T , Smart , R C , Wong , C Q and Conney , A H . 1988 . Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-o-tetradecanoylphorbol-13-acetate . Cancer Res , 48 : 5941 – 5946 .
   PubMed Web of Science ®Google Scholar
• Huang , M T , Lou , Y R , Ma , W , Newmark , H L Reuhl , K R . 1994 . Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice . Cancer Res , 54 : 5841 – 5847 .
   PubMed Web of Science ®Google Scholar
• Huang , M T , Ma , W , Yen , P , Xie , J G Han , J . 1997 . Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis . Carcinogenesis , 18 : 83 – 88 .
   PubMed Web of Science ®Google Scholar
• Rao , C V , Simi , B and Reddy , B S . 1993 . Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon . Carcinogenesis , 14 : 2219 – 2225 .
   PubMed Web of Science ®Google Scholar
• Rao , C V , Rivenson , Simi , B and Reddy , B S . 1995 . Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound . Cancer Res , 55 : 259 – 266 .
   PubMed Web of Science ®Google Scholar
• Perkins , S , Verschoyle , R D , Hill , K , Parveen , I Threadgill , M D . 2002 . Chemopreventive efficacy and pharmacokinetics of curcumin in the Min/+ mouse, a model of familial adenomatous polyposis . Cancer Epidem Biomark Prev , 11 : 535 – 540 .
   PubMed Web of Science ®Google Scholar
• Sharma , R A , Euden , S A , Platton , S L , Cooke , D N Shafayat , A . 2004 . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance . Clin Cancer Res , 10 : 6847 – 6854 .
   PubMed Web of Science ®Google Scholar
• Owen , R W . 1997 . Faecal steroids and colorectal carcinogenesis . Scand J Gastroenterol Suppl , 222 : 76 – 82 .
   PubMedGoogle Scholar
• Devasena , T , Rajasekaran , K N , Gunasekaran , G , Viswariathan , P and Menon , V P . 2003 . Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione a curcumin analog on DMH-induced colon cancer model . Pharmacol Res , 47 : 133 – 140 .
   PubMed Web of Science ®Google Scholar
• Rao , C V , Simi , B , Wynn , T T , Garr , K and Reddy , B S . 1996 . Modulating effect of amount and types of dietary fat on colonic mucosal phospholipase A2, phosphatidylinositol-specific phospholipase C activities, and cyclooxygenase metabolite formation during different stages of colon tumor promotion in male F344 rats . Cancer Res , 56 : 532 – 537 .
   PubMed Web of Science ®Google Scholar
• Reddy , S , Rishi , A K , Xu , H , Levi , E , Sarkar , F H and Majumdar , A PN . 2006 . Mechanisms of curcumin and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells . Nutr Cancer , 55 : 185 – 194 .
   PubMed Web of Science ®Google Scholar
• Zhang , F , Altorki , N K , Mestre , J R , Subbaramaiah , K and Dannenberg , A J . 1999 . Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells . Carcinogenesis , 20 : 445 – 451 .
   PubMed Web of Science ®Google Scholar
• Goel , A , Boland , C R and Chauhan , D P . 2001 . Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells . Cancer Lett , 172 : 111 – 118 .
   PubMed Web of Science ®Google Scholar
• Hanif , R , Qiao , L , Shiff , S J and Rigas , B . 1997 . Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway . J Lab Clin Med , 130 : 576 – 584 .
   PubMed Web of Science ®Google Scholar
• Barnes , C J and Lee , M . 1998 . Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin . Gastroenterology , 114 : 873 – 877 .
   PubMed Web of Science ®Google Scholar
• Cheng , A L , Hsu , C H , Lin , J K , Hsu , M M Ho , Y F . 2001 . Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions . Anticancer Res , 21 : 2895 – 2900 .
   PubMed Web of Science ®Google Scholar
• Sharma , R A , McLefland , H R , Hill , K A , Ireson , C R Euden , S A . 2001 . Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer . Clin Cancer Res , 7 : 1894 – 1900 .
   PubMed Web of Science ®Google Scholar
• Ravindranath , V and Chandrasekhara , N . 1980 . Absorption and tissue distribution of curcumin in rats . Toxicology , 16 : 259 – 265 .
   PubMed Web of Science ®Google Scholar
• Parveen , I and Threadgill , M D . 2000 . Labeled compounds of interest as anti-tumour agents-VII1. [3H]- and [14C]-curcumin . J Labeled Compd Radiopharm , 43 : 883 – 889 .
   Web of Science ®Google Scholar
• Pereira , M A , Grubbs , C J , Barnes , L H , Li , H Olson , G R . 1996 . Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats . Carcinogenesis , 17 : 1305 – 1311 .
   PubMed Web of Science ®Google Scholar
• Shishodia , S , Chaturvedi , M M and Aggarwal , B B . 2007 . Role of curcumin in cancer therapy . Curr Prob Cancer , 31 : 243 – 305 .
   PubMed Web of Science ®Google Scholar
• Egan , M E , Pearson , M , Weiner , S A , Rajendran , V Rubin , D . 2004 . Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects . Science , 304 : 600 – 602 .
   PubMed Web of Science ®Google Scholar
• Kuo , M L , Huang , T S and Lin , J K . 1996 . Curcumin, an antioxidant and antitumour promoter induces apoptosis in human leukemia cells . Biochem Biophys Acta , 1317 : 965 – 1000 .
   Web of Science ®Google Scholar
• Kawamori , T , Lubet , R , Steele , V E , Kelloff , G J Kaskey , R B . 1999 . Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of cancer . Cancer Res , 559 : 597 – 601 .
   Google Scholar
• Arbiser , J L , Klauber , N , Rohan , R , van Leeuwen , R Huang , M T . 1998 . Curcumin is an in vivo inhibitor of angiogenesis . Mol Med , 4 : 376 – 483 .
   PubMed Web of Science ®Google Scholar
• Garcea , G , Berry , D P , Jones , D J , Singh , R Dennison , A R . 2005 . Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their phrmacodynamic consequences . Cancer Epidemiol Biomarkers Prev , 14 : 120 – 125 .
   PubMed Web of Science ®Google Scholar
• Li , Y and Sarkar , F H . 2002 . Inhibition of nuclear factor κ B activation in PC3 cells by genistein is mediated via Akt signaling pathway . Clin Cancer Res , 8 : 2369 – 2377 .
   PubMed Web of Science ®Google Scholar
• Das , K C and White , C W . 1977 . Activation of NF-κ B by antineoplastic agents. Role of protein kinase C . J Biol Chem , 272 : 14914 – 14920 .
   Web of Science ®Google Scholar
• Chuang , S E , Yeh , P Y Lu , Y S . 2002 . Basal levels and patterns of anticancer drug-induced activation of nuclear factor κ B (NF-κ B), and its attention by tamoxifen, dexamethsone and curcumin in carcinoma cells . Biochem Pharmacol , 63 : 1709 – 1716 .
   PubMed Web of Science ®Google Scholar
• Heinemann , V , Boeck , S , Hinke , A , Labianca , R and Louvet , C . 2008 . Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer . BMC Cancer , 8 : 82 – 91 .
   PubMed Web of Science ®Google Scholar
• Fujioka , S , Sclabas , G M Schmidt , C . 2003 . Function of nuclear factor B in pancreatic cancer metastasis . Clin Cancer Res , 9 : 346 – 354 .
   PubMed Web of Science ®Google Scholar
• Kornmann , M , Ishiwata , T , Itakura , J , Tangvoranuntakul , P Beger , H G . 1998 . Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival . Oncology , 55 : 363 – 369 .
   PubMed Web of Science ®Google Scholar
• Kunnumakkara , A B , Guha , S , Krishnan , S , Diagaradjane , P Gelovani , J . 2007 . Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products . Cancer Res , 67 : 3853 – 3861 .
   PubMed Web of Science ®Google Scholar
• Lev-Ari , S , Vexler , A , Starr , A , Ashkenazy-Voghera , M Greif , J . 2007 . Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines . Cancer Invest , 25 : 411 – 418 .
   PubMed Web of Science ®Google Scholar
• Khanbolooki , S , Nawrocki , S T , Arumugam , T , Andtbacka , R Pino , M S . 2006 . Nuclear factor-kappa B maintains TRAIL resistance in human pancreatic cancer cells . Mol Cancer Ther , 5 : 2251 – 2260 .
   PubMed Web of Science ®Google Scholar
• Ashkenazi , A . 2002 . Targeting death and decoy receptors of the tumor-necrosis factor superfamily . Nat Rev Cancer , 2 : 420 – 430 .
   PubMed Web of Science ®Google Scholar
• Jung , E M , Park , J W , Choi , K S , Park , J W Lee , H I . 2006 . Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation . Carcinogenesis , 27 : 2008 – 2017 .
   PubMed Web of Science ®Google Scholar
• Patel , B B , Sengupta , R , Qazi , S , Vachhani , H Yu , Y . 2008 . Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R . Int J Cancer , 122 : 267 – 273 .
   PubMed Web of Science ®Google Scholar
• Koo , J Y , Kim , H J , Jung , K O and Park , K Y . 2004 . Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil . J Med Food , 7 : 117 – 721 .
   PubMed Web of Science ®Google Scholar
• Xu , H , Yu , Y , Marciniak , D J , Rishi , A Sarkar , F H . 2005 . EGFR-related protein (ERRP) Inhibits multiple members of EGFR family in colon and breast cancer Cells . Mol Cancer Ther , 4 : 435 – 442 .
   PubMed Web of Science ®Google Scholar
• Kunnumakkara , A B , Diagaradjane , P , Guha , S , Deorukhkar , A Shentu , S . 2004 . Curcumin sensitizes human colorectal cancer xenografts in nude mice to gamma-radiation by targeting nuclear factor-kappaB-regulated gene products . Clin Cancer Res , Apr 14 : 2128 – 2136 .
   Google Scholar